These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32829941)
1. [Erdheim-Chester disease presenting with bilateral orbital involvement: Report of three cases]. Kiratli H; Koç I; Söylemezoğlu F J Fr Ophtalmol; 2020 Nov; 43(9):851-857. PubMed ID: 32829941 [TBL] [Abstract][Full Text] [Related]
2. Orbital involvement in Erdheim-Chester disease. Lau WW; Chan E; Chan CW Hong Kong Med J; 2007 Jun; 13(3):238-40. PubMed ID: 17548915 [TBL] [Abstract][Full Text] [Related]
4. [Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience]. Adens A; Landy P; Terriou L; Baillet C; Beron A; Lambert M; Launay D; Huglo D Rev Med Interne; 2017 Apr; 38(4):235-242. PubMed ID: 28268124 [TBL] [Abstract][Full Text] [Related]
5. Intracranial mass lesions and skin discoloration in the armpits as unusual clues to Erdheim-Chester disease: a case report. Rodrigues PGB; Pereira IS; Lima Filho VB; Dias DA; Nóbrega PR; Braga-Neto P BMC Neurol; 2021 Feb; 21(1):81. PubMed ID: 33602153 [TBL] [Abstract][Full Text] [Related]
6. Vemurafenib (BRAF Inhibitor) Therapy for Orbital Erdheim-Chester Disease. Gupta A; Yeganeh A; Rootman D; Goldberg R Ophthalmic Plast Reconstr Surg; 2017; 33(6):e138-e139. PubMed ID: 28099231 [TBL] [Abstract][Full Text] [Related]
7. Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes. Park JK; Huang LC; Kossler AL Orbit; 2023 Jun; 42(3):233-244. PubMed ID: 35702885 [TBL] [Abstract][Full Text] [Related]
8. [Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement]. Berthe P; Rouzic N; Daelman L; Jacobzone C; Espitia A; Cohen-Aubart F; Haroche J; Émile JF; Lorleac'h A Rev Med Interne; 2020 Jun; 41(6):413-417. PubMed ID: 32113636 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature]. Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869 [TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, imaging and response to interferon-alpha therapy in Erdheim-Chester disease: case-based review. Iaremenko O; Petelytska L; Dyadyk O; Negria N; Fedkov D Rheumatol Int; 2020 Sep; 40(9):1529-1536. PubMed ID: 32572610 [TBL] [Abstract][Full Text] [Related]
11. [Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?]. Parreau S; Haroche J; Pommepuy I; Emile JF; Bourras JC; Archambeaud F Rev Med Interne; 2017 Jul; 38(7):482-487. PubMed ID: 27889325 [TBL] [Abstract][Full Text] [Related]
16. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports. Qiao J; Ma R; Peng X; He W World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276 [TBL] [Abstract][Full Text] [Related]
17. A cytologic diagnosis of BRAF Chasseur P; Kyriakopoulou M; Vokaer B; Beukinga I; Casado Arroyo R; Cogan E; Couturier B Acta Clin Belg; 2017 Oct; 72(5):369-371. PubMed ID: 28222655 [TBL] [Abstract][Full Text] [Related]
18. Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. Tzoulis C; Schwarzlmüller T; Gjerde IO; Søfteland E; Neckelmann G; Biermann M; Haroche J; Straume O; Vintermyr OK BMC Res Notes; 2015 Apr; 8():171. PubMed ID: 25926131 [TBL] [Abstract][Full Text] [Related]
19. Erdheim-Chester Disease: a comprehensive review of the literature. Mazor RD; Manevich-Mazor M; Shoenfeld Y Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030 [TBL] [Abstract][Full Text] [Related]
20. Neurological form of Erdheim-Chester disease : Case report and review of the literature. Perez A; Crahes M; Laquerrière A; Proust F; Derrey S Neurochirurgie; 2014 Dec; 60(6):316-20. PubMed ID: 25441710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]